/CYRX

Cryoport Inc

CYRX

$15.55USD↑+1.83%+0.28 today

MARKET CAP

787.6M

P/E (TTM)

11.6x

FWD P/E

—

DAY RANGE

$15 – $16

52W RANGE

$8

$17

AI Summary

Stalk

Buy NowMedium

CYRX remains in a healthy uptrend with price above rising 9/20/50 EMAs and forming higher highs and higher lows. The recent pullback into the 20-day and 50-day EMAs in the $15.84–$15.09 area has held, demonstrating demand absorption at key support. Momentum indicators remain neutral, providing room for further upside without overbought constraints. Given the continuation structure and steady EMAs, we recommend initiating a long position now on this pullback into support, while monitoring resistance at prior highs. Primary risks include a breakdown below the EMAs and failure to clear the $16.42 resistance level.

↑Revenue up 15% YoY to $49M driven by life sciences services
↑Achieved first positive adjusted EBITDA of $0.4M, boosting profit runway
↓Guidance held at $192–196M due to geopolitical and macro uncertainties

Full analysis →

Buying

4

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	4.22 M	66.23 M	+237.54 K	+100.9%	0.00%
CC Cadian Capital Management, LP Q2 2026	SELL	2.92 M	45.85 M	+-1.86 M	+15.9%	3.47%
MM Millennium Management LLC Q2 2026	SELL	1.72 M	27.08 M	+-1.25 M	+10.1%	0.01%
AC Aqr Capital Management LLC Q2 2026	BUY	400.36 K	6.29 M	+64.47 K	+126.0%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	381.77 K	5.99 M	+74.09 K	+135.3%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	372.40 K	5.85 M	+4.29 K	+91.8%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	177.86 K	2.90 M	+-9.09 K	+96.3%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	751.00	11.79 K	+-840.00	-10.5%	0.00%
MG Man Group Plc Q2 2026	SELL	0.00	0.00	+-18.25 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-10.49 K	-100.0%	0.00%